Global Fosinopril Sodium Tablets Market Growth 2026-2032

The global Fosinopril Sodium Tablets market size is predicted to grow from US$ 201 million in 2025 to US$ 270 million in 2032; it is expected to grow at a CAGR of 4.4% from 2026 to 2032.

Fosinopril sodium is an ACE inhibitor drug prescribed for treatment of high blood pressure and congestive heart failure, and for treatment after a heart attack.

United States market for Fosinopril Sodium Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Fosinopril Sodium Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Fosinopril Sodium Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Fosinopril Sodium Tablets players cover Bristol Myers Squibb, Zhejiang Huahai Pharmaceutical, Teva Pharmaceuticals, Sandoz, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LP Information, Inc. (LPI) ' newest research report, the “Fosinopril Sodium Tablets Industry Forecast” looks at past sales and reviews total world Fosinopril Sodium Tablets sales in 2025, providing a comprehensive analysis by region and market sector of projected Fosinopril Sodium Tablets sales for 2026 through 2032. With Fosinopril Sodium Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Fosinopril Sodium Tablets industry.

This Insight Report provides a comprehensive analysis of the global Fosinopril Sodium Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Fosinopril Sodium Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Fosinopril Sodium Tablets market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Fosinopril Sodium Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Fosinopril Sodium Tablets.

This report presents a comprehensive overview, market shares, and growth opportunities of Fosinopril Sodium Tablets market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
10mg
20mg
40mg

Segmentation by Application:
Hospital
Clinic
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Bristol Myers Squibb
Zhejiang Huahai Pharmaceutical
Teva Pharmaceuticals
Sandoz

Key Questions Addressed in this Report

What is the 10-year outlook for the global Fosinopril Sodium Tablets market?

What factors are driving Fosinopril Sodium Tablets market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Fosinopril Sodium Tablets market opportunities vary by end market size?

How does Fosinopril Sodium Tablets break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver. Show more